Carvedilol is a non-selective beta-adrenergic and selective alpha-1 receptor blocker used in hypertension, stable angina and heart failure with reduced ejection fraction, where its combination of vasodilation and cardiac-output support provides dual haemodynamic benefit. Simson Pharma's Carvedilol reference standard and impurities support high-volume compendial testing for this major cardiovascular generic.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Carvedilol Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.